You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood ependymoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Ependymoma, Recurrent Childhood, Ependymoma Trial in Denver, Orlando (Granulocyte Macrophage Colony Stimulation Factor)

      Active, not recruiting
      • Ependymoma, Recurrent Childhood
      • Ependymoma
      • Granulocyte Macrophage Colony Stimulation Factor
      • Denver, Colorado
      • +1 more
      Feb 8, 2022

      CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

      Recruiting
      • Central Nervous System Tumor
      • +10 more
      • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +35 more
      • Birmingham, Alabama
      • +113 more
      Jun 28, 2022

      Ependymoma Trial in Memphis, Toronto (radiation, procedure, drug, device)

      Active, not recruiting
      • Ependymoma
      • Irradiation
      • +5 more
      • Memphis, Tennessee
      • +1 more
      Oct 28, 2022

      Recurrent Ependymoma Trial in Houston (5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group

      Recruiting
      • Recurrent Ependymoma
      • 5-Azacytidine (5-AZA) group 1
      • +2 more
      • Houston, Texas
        The University of Texas Health Science Center at Houston
      Aug 17, 2022

      Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +31 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +118 more
      Jan 27, 2023

      Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma Trial in Houston (Laboratory Biomarker

      Completed
      • Recurrent Childhood Medulloblastoma
      • +2 more
      • Laboratory Biomarker Analysis
      • Natural Killer Cell Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 31, 2020

      Ependymoma Trial in New York (HER2 Specific CAR T Cell)

      Recruiting
      • Ependymoma
      • HER2 Specific CAR T Cell
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Apr 6, 2022

      Posterior Fossa Ependymoma (PFEPN) Trial in Aurora (Trastuzumab after SubQ GM-CSF, Trastuzumab in combination with SubQ GM-CSF)

      Recruiting
      • Posterior Fossa Ependymoma (PFEPN)
      • Trastuzumab after SubQ GM-CSF
      • Trastuzumab in combination with SubQ GM-CSF
      • Aurora, Colorado
        Children's Hospital Colorado
      Dec 2, 2021

      Ependymoma Trial in Pittsburgh (biological, drug, other)

      Recruiting
      • Ependymoma
      • HLA-A2 restricted synthetic tumor antigen
      • +5 more
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of UPMC
      Oct 23, 2022

      Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

      Active, not recruiting
      • Malignant Glioma
      • +2 more
      • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
      • Concurrent Optune and RT followed by Optune System alone
      • Los Angeles, California
      • +8 more
      Jan 17, 2023

      High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

      Recruiting
      • High Grade Glioma
      • +12 more
      • LUTATHERA® (Lutetium Lu 177 dotatate)
      • Aurora, Colorado
      • +8 more
      Jan 16, 2023

      Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

      Recruiting
      • Ependymoma
      • +3 more
      • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
      • Duarte, California
        City of Hope Medical Center
      Mar 9, 2022

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

      Active, not recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • EGFR806-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Jan 18, 2023

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

      Recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • HER2-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Dec 14, 2022

      Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

      Recruiting
      • Diffuse Midline Glioma (DMG)
      • +7 more
      • ONC206
      • Standard of Care Radiation Therapy
      • San Francisco, California
      • +2 more
      Sep 13, 2022

      Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

      Recruiting
      • Malignant Solid Neoplasm
      • +26 more
      • Birmingham, Alabama
      • +121 more
      Aug 24, 2022

      FFPE Samples From Younger Patients With Rhabdomyosarcoma

      Completed
      • Alveolar Childhood Rhabdomyosarcoma
      • +2 more
        • Jinan, Shandong, China
          Jinan central hospital affiliated to Shandong First Medical Univ
        Sep 10, 2023

        Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +30 more
        • Larotrectinib Sulfate
        • Birmingham, Alabama
        • +123 more
        Aug 23, 2022

        Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

        Recruiting
        • Malignant Solid Neoplasm
        • +40 more
        • Biospecimen Collection
        • +6 more
        • Birmingham, Alabama
        • +172 more
        Jan 27, 2023

        Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +32 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Birmingham, Alabama
        • +124 more
        Aug 24, 2022

        Childhood Asthma With Acute Exacerbation Trial in Gentofte, Naestved (Azithromycin, Placebo mixture)

        Active, not recruiting
        • Childhood Asthma With Acute Exacerbation
        • Gentofte, Copenhagen, Denmark
        • +1 more
        Nov 21, 2022

        CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

        Recruiting
        • Central Nervous System Neoplasms
        • +22 more
        • Bethesda, Maryland
          National Institutes of Health
        Mar 1, 2022